Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 13 March 1987:
Vol. 235. no. 4794, pp. 1348 - 1352
DOI: 10.1126/science.3029867

Articles

Science, Vol 235, Issue 4794, 1348-1352
Copyright © 1987 by American Association for the Advancement of Science


articles

The regulation of natural anticoagulant pathways

CT Esmon

Vascular endothelium plays an active role in preventing blood clot formation in vivo. One mechanism by which prevention is achieved involves a cell surface thrombin-binding protein, thrombomodulin, which converts thrombin into a protein C activator. Activated protein C then functions as an anticoagulant by inactivating two regulatory proteins of the coagulation system, factors Va and VIIIa. The physiological relevance of the protein C anticoagulant pathway is demonstrated by the identification of homozygous protein C--deficient infants with severe thrombotic complications. Recent studies suggest that this pathway provides a link between inflammation and coagulation.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Proteolytic Cleavage of High Mobility Group Box 1 Protein by Thrombin-Thrombomodulin Complexes.
T. Ito, K.-i. Kawahara, K. Okamoto, S. Yamada, M. Yasuda, H. Imaizumi, Y. Nawa, X. Meng, B. Shrestha, T. Hashiguchi, et al. (2008)
Arterioscler Thromb Vasc Biol 28, 1825-1830
   Abstract »    Full Text »    PDF »
Tissue-Specific Hemostasis in Mice.
N. Mackman (2005)
Arterioscler Thromb Vasc Biol 25, 2273-2281
   Abstract »    Full Text »    PDF »
Protein C and/or S deficiency presenting as peripheral arterial insufficiency.
Y P Cho, T-W Kwon, J-H Ahn, G H Kang, M S Han, Y H Kim, J H Kwak, and S G Lee (2005)
Br. J. Radiol. 78, 601-605
   Abstract »    Full Text »    PDF »
Crystal Structure of Anticoagulant Thrombin Variant E217K Provides Insights into Thrombin Allostery.
W. J. Carter, T. Myles, C. S. Gibbs, L. L. Leung, and J. A. Huntington (2004)
J. Biol. Chem. 279, 26387-26394
   Abstract »    Full Text »    PDF »
Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide.
A. W. Rijneveld, S. Weijer, S. Florquin, C. T. Esmon, J. C. M. Meijers, P. Speelman, P. H. Reitsma, H. Ten Cate, and T. van der Poll (2004)
Blood 103, 1702-1709
   Abstract »    Full Text »    PDF »
Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase: Comparison with unfractionated heparin.
T. Sakamoto, H. Ogawa, K. Takazoe, M. Yoshimura, H. Shimomura, Y. Moriyama, H. Arai, and K. Okajima (2003)
J. Am. Coll. Cardiol. 42, 1389-1394
   Abstract »    Full Text »    PDF »
Infections and endothelial cells.
T. T Keller, A. T.A Mairuhu, M. D de Kruif, S. K Klein, V. E.A Gerdes, H. ten Cate, D. P.M Brandjes, M. Levi, and E. C.M van Gorp (2003)
Cardiovasc Res 60, 40-48
   Abstract »    Full Text »    PDF »
The Potential Role of Direct Thrombin Inhibitors in the Prevention and Treatment of Venous Thromboembolism.
J. A. Heit (2003)
Chest 124 , 40S-48S
   Abstract »    Full Text »    PDF »
Roles of Low Specificity and Cofactor Interaction Sites on Thrombin during Factor XIII Activation: COMPETITION FOR COFACTOR SITES ON THROMBIN DETERMINES ITS FATE.
H. Philippou, J. Rance, T. Myles, S. W. Hall, R. A. Ariens, P. J. Grant, L. Leung, and D. A. Lane (2003)
J. Biol. Chem. 278, 32020-32026
   Abstract »    Full Text »    PDF »
Expression and function of the endothelial protein C receptor in human neutrophils.
D. H. Sturn, N. C. Kaneider, C. Feistritzer, A. Djanani, K. Fukudome, and C. J. Wiedermann (2003)
Blood 102, 1499-1505
   Abstract »    Full Text »    PDF »
Deep venous thrombosis associated with protein C and/or S deficiency: management with catheter-directed thrombolysis.
Y P Cho, H J Jang, D H Lee, J Ahn, M S Han, J S Kim, Y H Kim, and S G Lee (2003)
Br. J. Radiol. 76, 380-384
   Abstract »    Full Text »    PDF »
Thrombin and Vascular Development: A Sticky Subject.
M. Moser and C. Patterson (2003)
Arterioscler Thromb Vasc Biol 23, 922-930
   Abstract »    Full Text »    PDF »
Increased Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels in Normotensive Type 2 Diabetic Patients with Microalbuminuria.
Y. Yano, N. Kitagawa, E. C. Gabazza, K. Morioka, H. Urakawa, T. Tanaka, A. Katsuki, R. Araki-Sasaki, Y. Hori, K. Nakatani, et al. (2003)
J. Clin. Endocrinol. Metab. 88, 736-741
   Abstract »    Full Text »    PDF »
Extrahepatic Synthesis of Factor VII in Human Atherosclerotic Vessels.
J. N. Wilcox, S. Noguchi, and J. Casanova (2003)
Arterioscler Thromb Vasc Biol 23, 136-141
   Abstract »    Full Text »    PDF »
Factor V: a combination of Dr Jekyll and Mr Hyde.
K. G. Mann and M. Kalafatis (2003)
Blood 101, 20-30
   Full Text »    PDF »
Peripheral arterial insufficiency associated with protein C deficiency.
Y P Cho, D H Lee, H J Jang, J S Kim, M S Han, and S G Lee (2002)
Br. J. Radiol. 75, 843-846
   Abstract »    Full Text »    PDF »
Rho-GTPase-Dependent Platelet-Neutrophil Interaction Affected by HMG-CoA Reductase Inhibition With Altered Adenosine Nucleotide Release and Function.
N. C. Kaneider, P. Egger, S. Dunzendorfer, and C. J. Wiedermann (2002)
Arterioscler Thromb Vasc Biol 22, 1029-1035
   Abstract »    Full Text »    PDF »
Insulin Resistance Is Associated with Increased Circulating Level of Thrombin-Activatable Fibrinolysis Inhibitor in Type 2 Diabetic Patients.
Y. Hori, E. C. Gabazza, Y. Yano, A. Katsuki, K. Suzuki, Y. Adachi, and Y. Sumida (2002)
J. Clin. Endocrinol. Metab. 87, 660-665
   Abstract »    Full Text »    PDF »
Adenoviral-Mediated Transfer of Tissue Plasminogen Activator Gene into Brain Capillary Endothelial Cells In Vitro.
J. Ai Kim, C. C. Hedrick, Dangci Xie, and M. J. Fisher (2001)
Angiology 52, 627-634
   Abstract »    PDF »
Intratracheal Administration of Activated Protein C Inhibits Bleomycin-induced Lung Fibrosis in the Mouse.
H. YASUI, E. C. GABAZZA, S. TAMAKI, T. KOBAYASHI, O. HATAJI, H. YUDA, S. SHIMIZU, K. SUZUKI, Y. ADACHI, and O. TAGUCHI (2001)
Am. J. Respir. Crit. Care Med. 163, 1660-1668
   Abstract »    Full Text »    PDF »
Adrenomedullin Inhibits Angiotensin II-Induced Expression of Tissue Factor and Plasminogen Activator Inhibitor-1 in Cultured Rat Aortic Endothelial Cells.
T. Sugano, H. Tsuji, H. Masuda, H. Nishimura, M. Yoshizumi, H. Kawano, S. Kimura, N. Ukimura, S. Yano, Y. Kunieda, et al. (2001)
Arterioscler Thromb Vasc Biol 21, 1078-1083
   Abstract »    Full Text »    PDF »
arboxypeptidase U at the Interface Between Coagulation and Fibrinolysis.
K. Schatteman, F. Goossens, J. Leurs, R. Verkerk, S. Scharpe, J. J. Michiels, and D. Hendriks (2001)
Clinical and Applied Thrombosis/Hemostasis 7, 93-101
   Abstract »    PDF »
Cytokines, Endothelium, and Adhesive Molecules in Pathologic Thrombopoiesis.
V. Cobankara, B. Oran, D. Ozatli, I. C. Haznedaroglu, A. Kosar, Y. Buyukasik, O. Ozcebe, S. Dundar, and S. Kirazli (2001)
Clinical and Applied Thrombosis/Hemostasis 7, 126-130
   Abstract »    PDF »
Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block.
B Isermann, S. Hendrickson, K Hutley, M Wing, and H Weiler (2001)
Development 128, 827-838
   Abstract »    PDF »
Pharmacological Profile of Recombinant, Human Activated Protein C (LY203638) in a Canine Model of Coronary Artery Thrombosis.
C. V. Jackson, B. D. Bailey, and T. J. Shetler (2000)
J. Pharmacol. Exp. Ther. 295, 967-971
   Abstract »    Full Text »
Changes of Hemostatic Molecular Markers After Gynecological Surgery.
K. Noda, H. Wada, N. Yamada, N. Noda, E. C. Gabazza, K. Kumeda, T. Okugawa, K. Yanoh, M. Ito, T. Nakano, et al. (2000)
Clinical and Applied Thrombosis/Hemostasis 6, 197-201
   Abstract »    PDF »
Decreased Protein C Activation Is Associated With Abnormal Collagen Turnover in the Intraalveolar Space of Patients With Interstitial Lung Disease.
H. Yasui, E. C. Gabazza, O. Taguchi, J. Risteli, L. Risteli, H. Wada, H. Yuda, T. Kobayashi, H. Kobayashi, K. Suzuki, et al. (2000)
Clinical and Applied Thrombosis/Hemostasis 6, 202-205
   Abstract »    PDF »
Contribution of ecto-5'-nucleotidase to the inhibition of platelet aggregation by human endothelial cells.
Y. Kawashima, T. Nagasawa, and H. Ninomiya (2000)
Blood 96, 2157-2162
   Abstract »    Full Text »    PDF »
Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients.
C. Giusti, R. Schiaffini, C. Brufani, A. Pantaleo, E. M. Vingolo, and P. Gargiulo (2000)
Br J Ophthalmol 84, 591-595
   Abstract »    Full Text »
Role of Activated Protein C in Helicobacter pylori-Associated Gastritis.
S. Oka, E. C. Gabazza, Y. Taguchi, M. Yamaguchi, S. Nakashima, K. Suzuki, Y. Adachi, and I. Imoto (2000)
Infect. Immun. 68, 2863-2869
   Abstract »    Full Text »    PDF »
Hemostatic Abnormalities in Patients With Thrombotic Complications on Maintenance Hemodialysis.
A. Inoue, H. Wada, M. Takagi, M. Yamamuro, K. Mukai, T. Nakasaki, M. Shimura, K. Hiyoyama, H. Deguchi, E. C. Gabazza, et al. (2000)
Clinical and Applied Thrombosis/Hemostasis 6, 100-103
   Abstract »    PDF »
Thrombomodulin as a New Marker of Lesion-Induced Astrogliosis: Involvement of Thrombin through the G-Protein-Coupled Protease-Activated Receptor-1.
A. Pindon, M. Berry, and D. Hantai (2000)
J. Neurosci. 20, 2543-2550
   Abstract »    Full Text »    PDF »
Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S.
M. Makris, M. Leach, N. J. Beauchamp, M. E. Daly, P. C. Cooper, K. K. Hampton, P. Bayliss, I. R. Peake, G. J. Miller, and F. E. Preston (2000)
Blood 95, 1935-1941
   Abstract »    Full Text »    PDF »
Identification and characterization of a thrombomodulin gene mutation coding for an elongated protein with reduced expression in a kindred with myocardial infarction.
G. Kunz, H. A. Ireland, P. J. Stubbs, M. Kahan, G. C. Coulton, and D. A. Lane (2000)
Blood 95, 569-576
   Abstract »    Full Text »    PDF »
Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription.
E. M. Boyle Jr, T. G. Canty Jr, E. N. Morgan, W. Yun, T. H. Pohlman, and E. D. Verrier (1999)
Ann. Thorac. Surg. 68, 1949-1953
   Abstract »    Full Text »    PDF »
Chemokines in Lung Injury: Thomas A. Neff Lecture.
R. M. Strieter, S. L. Kunkel, M. P. Keane, and T. J. Standiford (1999)
Chest 116 , 103S-110S
   Full Text »
State-of-the-Art Review : Increased Activated Protein C: Protein C Inhibitor Complex and Decreased Protein C Inhibitor Levels in Patients with Chronic Renal Failure on Maintenance Hemodialysis.
M. Takagi, H. Wada, K. Mukai, K. Minamikawa, Y. Wakita, K. Deguchi, N. Junji, T. Hayashi, K. Suzuki, and H. Shiku (1999)
Clinical and Applied Thrombosis/Hemostasis 5, 113-116
   Abstract »    PDF »
Extrahepatic Expression and Regulation of Protein C in the Mouse.
K. Yamamoto and D. J. Loskutoff (1998)
Am. J. Pathol. 153, 547-555
   Abstract »    Full Text »    PDF »
The C-terminal Region of the Factor V B-domain Is Crucial for the Anticoagulant Activity of Factor V.
E. Thorelli, R. J. Kaufman, and B. Dahlback (1998)
J. Biol. Chem. 273, 16140-16145
   Abstract »    Full Text »    PDF »
Rapid Activation of Protein C by Factor Xa and Thrombin in the Presence of Polyanionic Compounds.
A. R. Rezaie (1998)
Blood 91, 4572-4580
   Abstract »    Full Text »    PDF »
Protein C Anticoagulant System in Patients with Interstitial Lung Disease.
H. KOBAYASHI, E. C. GABAZZA, O. TAGUCHI, H. WADA, H. TAKEYA, J. NISHIOKA, H. YASUI, T. KOBAYASHI, O. HATAJI, K. SUZUKI, et al. (1998)
Am. J. Respir. Crit. Care Med. 157, 1850-1854
   Abstract »    Full Text »    PDF »
Monoclonal Anti-Cardiolipin Antibodies from New Zealand Black x New Zealand White F1 Mice React to Thrombomodulin.
K. Haruta, S. Kobayashi, S. Hirose, A. Horiai, M. Ohyanagi, M. Tanaka, T. Kawano, T. Shirai, Y. Takasaki, and H. Hashimoto (1998)
J. Immunol. 160, 253-258
   Abstract »    Full Text »    PDF »
Circulating Activated Endothelial Cells in Sickle Cell Anemia.
A. Solovey, Y. Lin, P. Browne, S. Choong, E. Wayner, and R. P. Hebbel (1997)
N. Engl. J. Med. 337, 1584-1590
   Abstract »    Full Text »    PDF »
Intrinsic Anticoagulation: Protein C, Protein S, and Thrombomodulin.
J. L. Mac Hale, N. Nathan, and M. D'Ambra (1997)
Seminars in Cardiothoracic and Vascular Anesthesia 1, 319-332
   Abstract »    PDF »
Protein C Activation and Factor Va Inactivation on Human Umbilical Vein Endothelial Cells.
M. F. Hockin, M. Kalafatis, M. Shatos, and K. G. Mann (1997)
Arterioscler Thromb Vasc Biol 17, 2765-2775
   Abstract »    Full Text »
Thrombomodulin Expression in Bovine Brain Capillaries : Anticoagulant Function of the Blood-Brain Barrier, Regional Differences, and Regulatory Mechanisms.
L. Wang, N. D. Tran, M. Kittaka, M. J. Fisher, S. S. Schreiber, and B. V. Zlokovic (1997)
Arterioscler Thromb Vasc Biol 17, 3139-3146
   Abstract »    Full Text »
Thrombomodulin Gene Mutations Associated With Myocardial Infarction.
H. Ireland, G. Kunz, K. Kyriakoulis, P. J. Stubbs, and D. A. Lane (1997)
Circulation 96, 15-18
   Abstract »    Full Text »
Functional Requirements for Inhibition of Thrombin by Antithrombin III in the Presence and Absence of Heparin.
M. Tsiang, A. K. Jain, and C. S. Gibbs (1997)
J. Biol. Chem. 272, 12024-12029
   Abstract »    Full Text »    PDF »
Factor VLeiden and Thrombophilia.
M. Kalafatis and K. G. Mann (1997)
Arterioscler Thromb Vasc Biol 17, 620-627
   Full Text »
A Single Genetic Origin for a Common Caucasian Risk Factor for Venous Thrombosis.
A. Zivelin, J. H. Griffin, X. Xu, I. Pabinger, M. Samama, J. Conard, B. Brenner, A. Eldor, and U. Seligsohn (1997)
Blood 89, 397-402
   Abstract »    Full Text »    PDF »
The Amino Terminal Lectin-Like Domain of Thrombomodulin Is Required for Constitutive Endocytosis.
E. M. Conway, S. Pollefeyt, D. Collen, and M. Steiner-Mosonyi (1997)
Blood 89, 652-661
   Abstract »    Full Text »    PDF »
Complement C5b-9 Increases Plasminogen Binding and Activation on Human Endothelial Cells.
V. J. Christiansen, P. J. Sims, and K. K. Hamilton (1997)
Arterioscler Thromb Vasc Biol 17, 164-171
   Abstract »    Full Text »
Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos.
H Weiler-Guettler, W. Aird, H Rayburn, M Husain, and R. Rosenberg (1996)
Development 122, 2271-2281
   Abstract »    PDF »
Magnesium(II) Is a Crucial Constituent of the Blood Coagulation Cascade.
F. Sekiya, M. Yoshida, T. Yamashita, and T. Morita (1996)
J. Biol. Chem. 271, 8541-8544
   Abstract »    Full Text »    PDF »
Oxidized Low Density Lipoprotein Reduces Thrombomodulin Transcription in Cultured Human Endothelial Cells through Degradation of the Lipoprotein in Lysosomes.
H. Ishii, K. Kizaki, S. Horie, and M. Kazama (1996)
J. Biol. Chem. 271, 8458-8465
   Abstract »    Full Text »    PDF »
Antiphospholipid antibodies and thrombosis: assessment of the potential risk for thrombosis.
H. Salem (1996)
Lupus 5, 163-166
   PDF »
Coexistence of Hereditary Homocystinuria and Factor V Leiden -- Effect on Thrombosis.
H. Mandel, B. Brenner, M. Berant, N. Rosenberg, N. Lanir, C. Jakobs, B. Fowler, and U. Seligsohn (1996)
N. Engl. J. Med. 334, 763-768
   Abstract »    Full Text »    PDF »
Enhanced In Vivo Antithrombotic Effects of Endothelial Cells Expressing Recombinant Plasminogen Activators Transduced With Retroviral Vectors.
D. A. Dichek, J. Anderson, A. B. Kelly, S. R. Hanson, and L. A. Harker (1996)
Circulation 93, 301-309
   Abstract »    Full Text »
EFFECTS OF CRYOPRESERVATION ON THE PROLIFERATION AND ANTICOAGULANT ACTIVITY OF HUMAN SAPHENOUS VEIN ENDOTHELIAL CELLS.
L. S. Bambang, J. P. Mazzucotelli, M. Moczar, F. Beaujean, and D. Loisance (1995)
J. Thorac. Cardiovasc. Surg. 110, 998-1004
   Abstract »    Full Text »
Determinants of Thrombin Receptor Cleavage.
K. Ishii, R. Gerszten, Y. W. Zheng, J. B. Welsh, C. W. Turck, and S. R. Coughlin (1995)
J. Biol. Chem. 270, 16435-16440
   Abstract »    Full Text »    PDF »
Transcriptional Regulation of Tissue Factor Expression in Human Endothelial Cells.
G. C. N. Parry and N. Mackman (1995)
Arterioscler Thromb Vasc Biol 15, 612-621
   Abstract »    Full Text »
Rebound Increase in Thrombin Generation and Activity After Cessation of Intravenous Heparin in Patients With Acute Coronary Syndromes.
C. B. Granger, J. M. Miller, E. G. Bovill, A. Gruber, R. P. Tracy, M. W. Krucoff, C. Green, E. Berrios, R. A. Harrington, E. M. Ohman, et al. (1995)
Circulation 91, 1929-1935
   Abstract »    Full Text »
The Pathogenesis of Sepsis.
R. C. Bone (1991)
Ann Intern Med 115, 457-469
   Abstract »    PDF »
Background Review and Current Concepts of Reperfusion Injury.
J. M. Hallenbeck and A. J. Dutka (1990)
Arch Neurol 47, 1245-1254
   Abstract »    PDF »
Altered Coagulation in Cerebral Ischemia Platelet, Thrombin, and Plasmin Activity.
M. Fisher and R. Francis (1990)
Arch Neurol 47, 1075-1079
   Abstract »    PDF »
Recombinant gene expression in vivo within endothelial cells of the arterial wall.
E. Nabel, G Plautz, F. Boyce, J. Stanley, and G. Nabel (1989)
Science 244, 1342-1344
   Abstract »    PDF »
Heparin promotes the inactivation of antithrombin by neutrophil elastase.
R. Jordan, J Kilpatrick, and R. Nelson (1987)
Science 237, 777-779
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)